Drugs in exacerbation of psoriasis

https://doi.org/10.1016/S0190-9622(86)70265-XGet rights and content

Drugs that have been associated with the precipitation or exacerbation of psoriasis include lithium, beta adrenergic receptor blocking agents, and antimalarials. The withdrawal of corticosteroids has been reported to activate pustular psoriasis. Nonsteroidal anti-inflammatory drugs, such as indomethacin, have recently been reported to exacerbate psoriasis, although additional well-controlled studies are still needed. Drugs used for treatment of psoriasis will sometimes cause a flare because of irritation, phototoxicity, or hypersensitivity reaction resulting in a Koebner phenomenon. Because psoriasis is a very complex disease and its activity is often unpredictable, clinical studies on adverse drug effects on psoriasis have been difficult to conduct. This review evaluates clinical, histologic, and biochemical evidence in the literature for drug-associated onset or exacerbation of psoriasis.

References (129)

  • HE Wiley et al.

    Abnormal proliferation of uninvolved psoriatic epidermis: Differential induction by saline, propranolol, and tape stripping in vivo

    J Invest Dermatol

    (1979)
  • JC Leonard

    Oxprenolol and a psoriasis-like eruption

    Lancet

    (1975)
  • MGM Rowland et al.

    Exfoliative dermatitis and practolol

    Lancet

    (1972)
  • A Hensen et al.

    Sclerosing peritonitis and practolol and other letter

    Lancet

    (1975)
  • DC Baxter-Smith et al.

    Sclerosing peritonitis in a patient on timolol

    Lancet

    (1978)
  • DR Osborne

    Propranolol and Peyronie's disease

    Lancet

    (1977)
  • JS Yudkin

    Peyronie's disease in association with metoprolol

    Lancet

    (1977)
  • AJ Olansky

    Antimalarials and ophthalmologic safety

    J Am Acad Dermatol

    (1982)
  • T Bielicky

    Light-sensitive psoriasis and antimalarial drugs

    J Invest Dermatol

    (1963)
  • WB Harwell

    Quinidine-induced psoriasis

    J Am Acad Dermatol

    (1983)
  • JFJ Cade

    Lithium salts in the treatment of psychotic excitement

    Med J Aust

    (1949)
  • AJ McGennis

    Lithium carbonate and tetracycline interaction

    Br Med J

    (1978)
  • D Deandrea et al.

    Dermatological reactions to lithium: A critical review of the literature

    J Clin Psychopharmacol

    (1982)
  • MCY Heng

    Cutaneous manifestations of lithium toxicity

    Br J Dermatol

    (1982)
  • VR Shukla et al.

    Lithium and lupus-like syndrome

    JAMA

    (1982)
  • A Skott et al.

    Exacerbation of psoriasis during lithium treatment

    Br J Dermatol

    (1977)
  • E Wittkower et al.

    Emotional factors in skin diseases

  • I Skoven et al.

    Lithium compound treatment and psoriasis

    Arch Dermatol

    (1979)
  • D Sarantidis et al.

    A review and controlled study of cutaneous conditions associated with lithium carbonate

    Br J Psychiatry

    (1983)
  • LD Evans et al.

    Lithium carbonate and psoriasis

    Am J Psychiatry

    (1979)
  • GL Bakris et al.

    Dermatologic manifestations of lithium: A review

    Int J Psychiatry Med

    (1981)
  • J Reiffers et al.

    Manifestations cutanées provoquées par le lithium

    Dermatologica

    (1977)
  • NJ Lowe et al.

    Generalized pustular psoriasis precipitated by lithium carbonate

    Arch Dermatol

    (1978)
  • BJ Fox et al.

    Lithium-induced psoriasiform dermatitis

    J Assoc Military Dermatol

    (1984)
  • D Lambert et al.

    Manifestations cutanées des thérapeutiques par le lithium

    Ann Dermatol Venereol

    (1982)
  • H Mobacken et al.

    Different pathogenesis for psoriatic reaction to lithium and practolol?

    Br J Dermatol

    (1978)
  • C Pincelli et al.

    Psoriasi e carbonaao di litio

    G Ital Dermatol Venereol

    (1982)
  • JJ Voorhees et al.

    Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade; a defective chalone mechanism?

    Arch Dermatol

    (1971)
  • MJ Berridge et al.

    Inositol triphosphate, a novel second messenger in cellular signal transduction

    Nature

    (1984)
  • G Rothstein et al.

    Effect of lithium on neutrophil mass and production

    N Engl J Med

    (1978)
  • GS Lazarus et al.

    Psoriasis, polymorphonuclear leukocytes and lithium carbonate: An important clue

    Arch Dermatol

    (1979)
  • LA Fernandez et al.

    Perturbation of the human immune system by lithium

    Clin Exp Immunol

    (1980)
  • FJ Bloomfield et al.

    Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis

    Br J Dermatol

    (1983)
  • HR Kaplan et al.

    Antihypertensive drugs: Proposed sites and mechanisms of action

    Fed Proc

    (1981)
  • E Ross

    Biochemical properties of hormone sensitive adenylate cyclase

    Ann Rev Biochem

    (1980)
  • PB Molinoff

    Alpha- and beta-adrenergic receptor subtypes. Properties, distribution and regulation

    Drugs

    (1984)
  • WD Hager et al.

    Beta-blockers: The extended family

    Adv Intern Med

    (1984)
  • M Raff et al.

    Die Bedeutung adrenerger Rezeptoren fur die Dermatologie

    Hautarzt

    (1985)
  • K Yoshikawa et al.

    On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions

    Br J Dermatol

    (1975)
  • K Adachi et al.

    Prostaglandins and cyclic AMP in epidermis

    Br J Dermatol

    (1975)
  • Cited by (0)

    View full text